Isoxsuprine%252525252525252525252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine hydrochloride is a vasodilator with a weak beta-adrenergic agonist effect. It is thought to relax vascular smooth muscle, leading to vasodilation and potentially improved blood flow. ## Primary Indications Historically used for peripheral vascular diseases such as intermittent claudication and Raynaud's disease. Its efficacy in these indications is not well-established by robust clinical trials, and its use has declined. It may also be used off-label to prevent premature labor (tocolysis), though other agents are preferred. ## Adult Dosing * **Peripheral Vascular Disease:** 10 mg to 20 mg orally every 3 to 4 times daily. * **Tocolysis (Off-label):** 10 mg orally every 3 to 4 hours for up to 24 hours. Maximum dose is not well-defined for chronic use, but typically does not exceed 80 mg daily. ## Pediatric Dosing No established pediatric dosing. ## Dose Adjustments No specific dose adjustments are typically required for hepatic or renal impairment, but caution is advised due to potential accumulation and increased adverse effects. ## Contraindications * Hypersensitivity to isoxsuprine. * Should not be administered intravenously. * Use with extreme caution in patients with cardiac arrhythmias or significant cardiovascular disease. ## Adverse Effects Common: Nausea, vomiting, stomach upset, dizziness, drowsiness, weakness, flushing, and hypotension. Less Common: Tachycardia, palpitations, rash, blurred vision, and nervousness. ## Key Drug Interactions * **Antihypertensives:** May potentiate hypotensive effects. * **Beta-blockers:** Isoxsuprine's weak beta-agonist effect may be antagonized by beta-blockers. * **Other Vasodilators:** Additive hypotensive effects. ## Monitoring * Blood pressure and heart rate. * Symptoms of peripheral vascular disease (e.g., claudication). * Signs of tocolysis effectiveness and maternal side effects if used for premature labor. ## Clinical Pearls * The clinical benefit of isoxsuprine for peripheral vascular disease is controversial and lacks strong supporting evidence. * Due to its side effect profile and lack of robust efficacy data, its use for peripheral vascular disease is limited. * If used for tocolysis, it should be administered with caution and under close medical supervision, as other agents are generally preferred. --- *This information is intended for healthcare professionals. Please consult the most current prescribing information and relevant clinical guidelines for definitive guidance, as drug information can change.*